Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
Yixuan Sun, Mingfeng Xia, Hongmei Yan, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 2, pp. 374-387
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential
Frank Madeo, Didac Carmona‐Gutiérrez, Sebastian J. Hofer, et al.
Cell Metabolism (2019) Vol. 29, Iss. 3, pp. 592-610
Open Access | Times Cited: 506
Biological properties and clinical applications of berberine
Danyang Song, Jianyu Hao, Daiming Fan
Frontiers of Medicine (2020) Vol. 14, Iss. 5, pp. 564-582
Closed Access | Times Cited: 344
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 327
Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology
Jin Wang, Lin Wang, Guanhua Lou, et al.
Pharmaceutical Biology (2019) Vol. 57, Iss. 1, pp. 193-225
Open Access | Times Cited: 319
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
Zehua Zhao, Feng‐Zhi Xin, Yaqian Xue, et al.
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 9, pp. 1-14
Open Access | Times Cited: 252
The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 243
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
Xiaopeng Zhu, Hua Bian, Liu Wang, et al.
Free Radical Biology and Medicine (2019) Vol. 141, pp. 192-204
Closed Access | Times Cited: 196
The AMPK pathway in fatty liver disease
Chunqiu Fang, Jianheng Pan, Ning Qu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 189
Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene
Yamei Han, Zhimin Hu, Aoyuan Cui, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Berberine as a potential autophagy modulator
Reza Mohammadinejad, Zahra Ahmadi, Shima Tavakol, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14914-14926
Closed Access | Times Cited: 123
The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
Samukelisiwe Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110785-110785
Open Access | Times Cited: 116
Coptisine fromCoptis chinensisexerts diverse beneficial properties: A concise review
Jiasi Wu, Yu Luo, Donghang Deng, et al.
Journal of Cellular and Molecular Medicine (2019) Vol. 23, Iss. 12, pp. 7946-7960
Open Access | Times Cited: 87
Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
Tarun Belwal, Aarti Bisht, Hari Prasad Devkota, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 87
Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway
Yunyun Fang, Linlin Ji, Chaoyu Zhu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 76
The pharmacological activity of berberine, a review for liver protection
Mengting Zhou, Ying Deng, Meichen Liu, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173655-173655
Closed Access | Times Cited: 74
Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats
Fatma H. Shaker, Marwa O. El-Derany, Sara A. Wahdan, et al.
Life Sciences (2021) Vol. 269, pp. 119078-119078
Closed Access | Times Cited: 72
Berberine modulates deacetylation of PPARγ to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway
Yingxi Xu, Tianhao Yu, Guojing Ma, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 12, pp. 3173-3187
Open Access | Times Cited: 62
Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine
Huiling Tan, Yue Tong, Zhengfang Chen, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 1, pp. 66-88
Open Access | Times Cited: 51
Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects
Wei Wei, Qingxuan Zeng, Yan Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 2138-2151
Open Access | Times Cited: 44
Preparation, physicochemical characterization, and bioactivity evaluation of berberine-entrapped albumin nanoparticles
Fatema A. Younis, Samar R. Saleh, Sahar S. Abd El‐Rahman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Erjie Tian, Gaurav Sharma, Chongshan Dai
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1883-1883
Open Access | Times Cited: 38
The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
Jia-hua Feng, Kang Chen, Siyu Shen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115511-115511
Open Access | Times Cited: 28
Berberine prevents NAFLD and HCC by modulating metabolic disorders
Xinyue Lin, Jilei Zhang, Yajun Chu, et al.
Pharmacology & Therapeutics (2024) Vol. 254, pp. 108593-108593
Closed Access | Times Cited: 14
Lipidomics-based natural products for chronic kidney disease treatment
Ruiyan Zhang, Jingjing Wang, Chenguang Wu, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41620-e41620
Open Access | Times Cited: 1
Berberine alleviates nonalcoholic fatty liver induced by a high‐fat diet in mice by activating SIRT3
Xi Xu, Xiaopeng Zhu, Jinyun Bai, et al.
The FASEB Journal (2019) Vol. 33, Iss. 6, pp. 7289-7300
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top